PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Study to Describe the Safety of a Vaccine (Called 13vPnC) in Healthy People 18 to 49 Years of Age in India
- Conditions
- Pneumococcal Disease
- Interventions
- Biological: 13-valent pneumococcal conjugate vaccine
- First Posted Date
- 2022-04-14
- Last Posted Date
- 2024-04-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 200
- Registration Number
- NCT05329259
- Locations
- 🇮🇳
Calcutta School of Tropical Medicine, Kolkata, WEST Bengal, India
🇮🇳Nirmal Hospital Pvt Ltd., Surat, Gujarat, India
🇮🇳Jawahar Lal Nehru Medical College, Ajmer, Rajasthan, India
Safety and Effectiveness of Apixaban Compared to Warfarin in Secondary Prevention in Patients With Atrial Fibrillation
- First Posted Date
- 2022-04-11
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 193565
- Registration Number
- NCT05321810
- Locations
- 🇯🇵
Pfizer, Tokyo, Japan
Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant
- First Posted Date
- 2022-04-07
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 760
- Registration Number
- NCT05317416
- Locations
- 🇫🇷
Hôpital Saint Antoine, Paris Cedex 12, France
🇫🇷Hopital Lyon Sud, Pierre Benite, France
🇺🇸Banner Gateway Medical Center, Gilbert, Arizona, United States
Safety and Immunogenicity of RSVpreF Coadministered With SIIV in Adults ≥65 Years of Age
- Conditions
- Respiratory Syncytial Virus
- Interventions
- Biological: RSVpreF VaccineOther: PlaceboBiological: Seasonal Inactivated Influenza Vaccine
- First Posted Date
- 2022-03-29
- Last Posted Date
- 2023-10-27
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1471
- Registration Number
- NCT05301322
- Locations
- 🇦🇺
AusTrials - Taringa, Taringa, Queensland, Australia
🇦🇺Paratus Clinical Research Brisbane, Albion, Queensland, Australia
🇦🇺John Hunter Hospital, New Lambton Heights, New South Wales, Australia
A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.
- Conditions
- Myocarditis
- Interventions
- Diagnostic Test: Cardiac Imaging
- First Posted Date
- 2022-03-25
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 300
- Registration Number
- NCT05295290
- Locations
- 🇺🇸
Children's of Alabama, Birmingham, Alabama, United States
🇺🇸Connecticut Children's Medical Center, Hartford, Connecticut, United States
🇺🇸Nemours Children's Hospital, Delaware, Wilmington, Delaware, United States
Study to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real-life Treatment Outcomes in Hungary: Analysis of National Health Insurance Fund Database
- Conditions
- Chronic Myeloid Leukaemia
- First Posted Date
- 2022-03-18
- Last Posted Date
- 2023-10-27
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1484
- Registration Number
- NCT05286528
- Locations
- 🇭🇺
Pfizer, Budapest, Hungary
A Study To Evaluate The Pharmacokinetics, Excretion, Mass Balance and Metabolism of PF-07265803
- First Posted Date
- 2022-03-18
- Last Posted Date
- 2024-03-29
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 6
- Registration Number
- NCT05286281
- Locations
- 🇺🇸
Labcorp Clinical Research Unit, Madison, Wisconsin, United States
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- First Posted Date
- 2022-03-18
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 36
- Registration Number
- NCT05287126
- Locations
- 🇵🇱
Centrum Zdrowia MDM, Warszawa, Poland
🇸🇰Narodny ustav detskych chorob, Bratislava, Bratislavský KRAJ, Slovakia
🇺🇸Arkansas Children's (IP Address), Little Rock, Arkansas, United States
Relative Bioavailability Study of 4 Different Formulations of PF-07321332 Relative to the Commercial Tablet Formulation
- First Posted Date
- 2022-03-03
- Last Posted Date
- 2022-06-30
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT05263895
- Locations
- 🇺🇸
New Haven Clinical Research Unit, New Haven, Connecticut, United States
A Study to Learn About PAXLOVID (a Commercial Medicine) In People With COVID-19
- First Posted Date
- 2022-03-03
- Last Posted Date
- 2024-05-30
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 3346
- Registration Number
- NCT05263908
- Locations
- 🇯🇵
Pfizer Local County, Tokyo, Japan